Safety of Thiopurine Therapy in Inflammatory Bowel Disease

Chaparro, María; Ordás, Íngrid; Cabré, Eduard; García–Sánchez, Valle; Bastida, Guillermo; Peñalva, Mireia; Gomollón, Fernando; García-Planella, Esther; Merino, Olga; Gutiérrez, Ana; Esteve, María; Márquez, Lucía; Garcia-Sepulcre, Maria; Hinojosa, Joaquín; Vera, Isabel; Muñoz, Fernando; L. Mendoza, Juan; Luis Cabriada, José; Montoro, Miguel; Barreiro‐de Acosta, Manuel; Ceña, Gloria; Saro, Cristina; Aldeguer, Xavier; Barrio, Jésus; Luís Mate, José; P. Gisbert, Javier

doi:10.1097/mib.0b013e318281f28f

Public

Safety of Thiopurine Therapy in Inflammatory Bowel Disease

Published in Inflammatory Bowel Diseases • May 10, 2013

Authors:

María Chaparro

Íngrid Ordás

Eduard Cabré

Abstract

BACKGROUND: To evaluate the safety of thiopurines in patients with inflammatory bowel disease. To identify predictive factors associated with the development of thiopurine-induced adverse events. METHODS: Long-term incidence of adverse events was estimated in patients from a prospectively maintained...

Subject

Thiopurine methyltransferase

Medicine

Adverse effect

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!